Augmented case-only designs for randomized clinical trials with failure time endpoints
From MaRDI portal
Publication:2805175
Recommendations
- Case-Only Analysis of Treatment-Covariate Interactions in Clinical Trials
- Case-only approach to identifying markers predicting treatment effects on the relative risk scale
- Analysis of two-phase sampling data with semiparametric additive hazards models
- Case–Cohort Analysis with Accelerated Failure Time Model
- Case‐Cohort Designs and Analysis for Clustered Failure Time Data
Cites work
- scientific article; zbMATH DE number 3385132 (Why is no real title available?)
- A case-cohort design for epidemiologic cohort studies and disease prevention trials
- A pseudolikelihood approach to analysis of nested case-control studies
- Asymptotic distribution theory and efficiency results for case-cohort studies
- Asymptotic theory for nested case-control sampling in the Cox regression model
- Case-Only Analysis of Treatment-Covariate Interactions in Clinical Trials
- Computing the Cox model for case cohort designs
- Counter-matching: A stratified nested case-control sampling method
- Cox Regression with Incomplete Covariate Measurements
- Efficient estimation for case-cohort studies
- Estimation of Regression Coefficients When Some Regressors Are Not Always Observed
- Exposure stratified case-cohort designs
- Large sample theory for semiparametric regression models with two-phase, outcome dependent sampling.
- Multiplicative Models and Cohort Analysis
- On fitting Cox's proportional hazards models to survey data
- Partial likelihood
- Retrospective studies and failure time models
- Robust Variance Estimation for the Case-Cohort Design
- Semiparametric Estimation Exploiting Covariate Independence in Two‐Phase Randomized Trials
- The Robust Inference for the Cox Proportional Hazards Model
- The semiparametric case-only estimator
- Two-stage testing procedures with independent filtering for genome-wide gene-environment interaction
Cited in
(5)- Two‐stage penalized regression screening to detect biomarker–treatment interactions in randomized clinical trials
- Causal inference methods for vaccine sieve analysis with effect modification
- Case-only approach to identifying markers predicting treatment effects on the relative risk scale
- Statistics for Weighing Benefits and Harms in a Proposed Genetic Substudy of a Randomized Cancer Prevention Trial
- Case-Only Analysis of Treatment-Covariate Interactions in Clinical Trials
This page was built for publication: Augmented case-only designs for randomized clinical trials with failure time endpoints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2805175)